Abstract
Human V9V2 T cells recognise pyrophosphate-based antigens (phosphoantigens) and have multiple functions in innate and adaptive immunity, including a unique ability to activate other cells of the immune system. We used flow cytometry and ELISA to define the early cytokine profiles of V9V2 T cells stimulated in vitro with isopentenyl pyrophosphate (IPP) and (E)-4-hydroxy-3-methyl-but-2 enyl pyrophosphate (HMB-PP) in the absence and presence of IL-2 and IL-15. We show that fresh V9V2 T cells produce interferon- (IFN-) and tumour necrosis factor- (TNF-) within 4 hours of stimulation with phosphoantigen, but neither IL-10, IL-13, nor IL-17 was detectable up to 72 hours under these conditions. Cytokine production was not influenced by expression or lack, thereof, of CD4 or CD8. Addition of IL-2 or IL-15 caused expansion of IFN - producing V9V2 T cells, but did not enhance IFN- secretion after 2472 hours. Thus, phosphoantigen-stimulated V9V2 T cells have potential as Th1-biasing adjuvants for immunotherapy. Copyright 2010 Margaret R. Dunne et al.
Cite
CITATION STYLE
Doherty, D. G., Dunne, M. R., Mangan, B. A., & Madrigal-Estebas, L. (2010). Preferential Th1 cytokine profile of phosphoantigen-stimulated human v 9V 2 T cells. Mediators of Inflammation, 2010. https://doi.org/10.1155/2010/704941
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.